Cancer-associated fibroblasts and resistance to anticancer therapies: status, mechanisms, and countermeasures
2022 · Cancer Cell International · 171 citations
https://doi.org/10.1186/s12935-022-02599-7
B
Bo Shen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
67
Papers
1.2K
Citations
18
h-index
27
i10-index
Bo Shen is an academic researcher from Zhejiang University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Cancer Cells and Metastasis & Inflammatory Biomarkers in Disease Prognosis. The author has an h-index of 18, co-authored 57 publications.
ORCID: 0000-0001-9708-6098Papers by this author
worksCombination of Tertiary Lymphoid Structure and Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients With Hepatocellular Carcinoma
2022 · Frontiers in Immunology · 48 citations
https://doi.org/10.3389/fimmu.2021.788640
Associations of HER2 Mutation With Immune-Related Features and Immunotherapy Outcomes in Solid Tumors
2022 · Frontiers in Immunology · 17 citations
https://doi.org/10.3389/fimmu.2022.799988
Peripheral blood lymphocytes differentiation patterns in responses / outcomes to immune checkpoint blockade therapies in non-small cell lung cancer: a retrospective study
2023 · BMC Cancer · 13 citations
https://doi.org/10.1186/s12885-023-10502-4
Study on efficacy and safety of Huangqi Guizhi Wuwu decoction treatment for oxaliplatin induced peripheral neurotoxicity
2020 · Medicine · 11 citations
https://doi.org/10.1097/md.0000000000019923
Deep muscularis propria tumor invasion without lymph node metastasis as a unique subclassification of stage IB gastric cancer: a retrospective study
2022 · BMC Gastroenterology · 2 citations
https://doi.org/10.1186/s12876-021-02090-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat